CD44 and breast carcinoma: Correspondingly, ectopic CBY1 significantly decreased SOX2, Nanog, and CD44, the representative breast cancer stemness marker expressions both in mRNA (Fig. S5C) and protein (Fig. 5B) levels, implying that CBY1 has the ability to inhibit the stemness of BCSCs.